Jeon, Young-Tae <br/><br/>
Postischemic sevoflurane offers no additional neuroprotective benefit to preischemic dexmedetomidine.  [electronic resource] 

 -  Journal of neurosurgical anesthesiology  Apr 2013 
 - 184-90 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1537-1921 
<br/><br/><label>Standard No.: </label>10.1097/ANA.0b013e3182764d2a  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Actins--metabolism<br/>Anesthetics, Inhalation--therapeutic use<br/>Animals<br/>Apoptosis Regulatory Proteins--metabolism<br/>Blotting, Western<br/>Brain--pathology<br/>Dexmedetomidine--therapeutic use<br/>Hemoglobins--metabolism<br/>Hypnotics and Sedatives--therapeutic use<br/>In Situ Nick-End Labeling<br/>Ischemic Attack, Transient--pathology<br/>Ischemic Preconditioning--methods<br/>Methyl Ethers--therapeutic use<br/>Neuroprotective Agents<br/>Proto-Oncogene Proteins c-bcl-2--metabolism<br/>Rats<br/>Rats, Sprague-Dawley<br/>Reperfusion Injury--prevention & control<br/>Sevoflurane<br/>Tissue Embedding<br/>bcl-2-Associated X Protein--metabolism